MyMD Pharmaceuticals Announces Upcoming Presentation of Preclinical Rheumatoid Arthritis Data for Oral TNF- Inhibitor MYMD-1 at the Society of Toxicology 2023 Annual Meeting

MYMDDelisted Stock  USD 1.82  0.02  1.09%   
About 62% of MYMD Old's investor base is looking to short. The analysis of current outlook of investing in MYMD Old suggests that many traders are alarmed regarding MYMD Old's prospects. The current market sentiment, together with MYMD Old's historical and current headlines, can help investors time the market. In addition, many technical investors use MYMD Old stock news signals to limit their universe of possible portfolio assets.
  
BALTIMORE, February 28, 2023--MyMD Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing groundbreaking therapies for the treatment of serious and debilitating autoimmune and inflammatory diseases, announced that preclinical data from a study, conducted in partnership with Charles River Laboratories International, Inc., has been accepted for presentation at the upcoming Society of Toxicology 2023 Annual Meeting.

Read at finance.yahoo.com
Yahoo News
  

MYMD Old Fundamental Analysis

We analyze MYMD Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MYMD Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MYMD Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

MYMD Old is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

MYMD Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MYMD Old stock to make a market-neutral strategy. Peer analysis of MYMD Old could also be used in its relative valuation, which is a method of valuing MYMD Old by comparing valuation metrics with similar companies.

Peers

MYMD Old Related Equities

UBXUnity Biotechnology   34.59   
0%
100.0%
NBYNovaBay Pharmaceuticals   9.37   
0%
27.0%
PASGPassage Bio   1.52   
0%
4.0%
GOVXGeoVax Labs   1.36   
0%
3.0%
KZRKezar Life   1.06   
3.0%
0%
AVIRAtea Pharmaceuticals   2.10   
6.0%
0%
KROSKeros Therapeutics   2.22   
6.0%
0%
KRONKronos Bio   3.03   
8.0%
0%
LRMRLarimar Therapeutics   3.43   
9.0%
0%
LGNDLigand Pharmaceuticals   3.89   
11.0%
0%
REPLReplimune   4.08   
11.0%
0%
RXRXRecursion Pharmaceuticals   5.23   
15.0%
0%
BOLTBolt Biotherapeutics   5.26   
15.0%
0%
XBIOXenetic Biosciences   5.39   
15.0%
0%
NVCTNuvectis Pharma   5.83   
16.0%
0%
ORICOric Pharmaceuticals   6.35   
18.0%
0%
GOSSGossamer Bio   7.62   
22.0%
0%
LYELLyell Immunopharma   7.69   
22.0%
0%
REVBRevelation Biosciences   8.62   
24.0%
0%
LYRALyra Therapeutics   9.09   
26.0%
0%
DSGNDesign Therapeutics   11.02   
31.0%
0%
SRZNSurrozen   12.96   
37.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in MYMD Stock

If you are still planning to invest in MYMD Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MYMD Old's history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stocks Directory
Find actively traded stocks across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios